NLI
VRTX icon

Nippon Life Insurance’s Vertex Pharmaceuticals VRTX Stock Holding History

Nippon Life Insurance’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-10,032
Closed -$1.52M – 285
2017
Q3 		$1.52M Sell
10,032
-17
-0.2% -$2.56K 0.03% 212
2017
Q2 		$1.29M Sell
10,049
-634
-6% -$76.3K 0.02% 241
2017
Q1 		$1.17M Sell
10,683
-1,578
-13% -$139K 0.02% 274
2016
Q4 		$903K Buy
12,261
+1,165
+10% +$94.8K 0.02% 310
2016
Q3 		$968K Sell
11,096
-106
-0.9% -$10K 0.02% 279
2016
Q2 		$964K Sell
11,202
-298
-3% -$25.7K 0.02% 270
2016
Q1 		$914K Sell
11,500
-64
-0.6% -$5.79K 0.02% 267
2015
Q4 		$1.46M Buy
11,564
+87
+0.8% +$10.5K 0.04% 220
2015
Q3 		$1.2M Sell
11,477
-473
-4% -$60.8K 0.03% 257
2015
Q2 		$1.48M Buy
11,950
+546
+5% +$68.8K 0.04% 250
2015
Q1 		$1.34M Buy
11,404
+123
+1% +$14.7K 0.03% 256
2014
Q4 		$1.34M Buy
11,281
+1,363
+14% +$154K 0.03% 255
2014
Q3 		$1.11M Buy
+9,918
New +$944K 0.03% 247
2014
Q2 		– Sell
-13,668
Closed -$967K – 289
2014
Q1 		$967K Sell
13,668
-249
-2% -$19.7K 0.03% 246
2013
Q4 		$1.03M Buy
13,917
+208
+2% +$14.5K 0.03% 243
2013
Q3 		$1.04M Buy
+13,709
New +$1.09M 0.03% 240

Other funds holding VRTX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Nippon Life Insurance's VRTX Position: Q4 2017 in Review

Nippon Life Insurance sold out of Vertex Pharmaceuticals (VRTX) in Q4 2017, closing a stake of 10,032 shares — an estimated $1.52M sold.

Nippon Life Insurance first reported a position in VRTX in Q3 2013 and held it in 16 quarters. The position peaked at $1.52M in Q3 2017. 644 funds tracked by Wall St. Rank hold VRTX as of Q4 2017.

  • Nippon Life Insurance reported no remaining Vertex Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Nippon Life Insurance sold 10,032 Vertex Pharmaceuticals shares in Q4 2017, an estimated $1.52M.
  • Nippon Life Insurance first reported a position in Vertex Pharmaceuticals in Q3 2013 and held it in 16 quarters.
  • Nippon Life Insurance's Vertex Pharmaceuticals position peaked at $1.52M in Q3 2017.
  • 644 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2017.

Based on Nippon Life Insurance's 13F filing for Q4 2017, filed 13 Feb 2018.